In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sirtris Satisfies GSK's M&A Appetite

Executive Summary

Pathway-oriented platforms are rare, and dealmaking around them can be complicated: partner too early or for too little and you risk giving away the store. But Sirtris pulled it off, via M&A, when GSK tendered a whopping $720 million for it in April. The deal is another example of Pharma's interest in platform biotechs and its hunger for innovation. But the unique nature of Sirtris's platform -- broad, but around a single set of biological targets -- makes it more one-off than trend-setting.
Advertisement

Related Content

Discredited SIRT1 Stops DNA Damage In Neurons
Financings Of The Fortnight Follows OvaScience’s Unique Route To Going Public
The Allure Of High-Hanging Fruit: Why VCs and Biotech Execs See Value In Difficult Drug Targets
GSK's "Biotech-In-A-Pharma" R&D Model Makes Progress
Biopharma in 2008: What a Difference an Economic Crisis Makes
Pharmaceutical/Biotechnology Deal Statistics Quarterly, Q2 2008
Isis: Pondering Platform Power
Mining the Mitochondria for Clues to Cell Survival Mechanisms
GlaxoSmithKline Breaks Out of Its Small-Molecule Mind-Set
Profiles of Two Iconoclasts

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

IV003124

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel